Zoetis at a Glance

Our vision to be the most trusted and valued animal health company spans continents, species, and technologies enabling us to shape the future of animal care through the best, most innovative solutions brought to life by our dedicated global team of purpose-driven colleagues. 

70+

Our years of experience in animal health

100+

Countries in which Zoetis products are sold

14,100

Approximate number of Zoetis colleagues, as of December 31, 2023

$8.5 Billion

Annual revenue (2023)

66%1

Revenue from companion animal products

¹ Excludes revenue associated with Client Supply Services and Human Health, which represented 1% of total 2023 revenue

34%1

Revenue from farm animal products

¹ Excludes revenue associated with Client Supply Services and Human Health, which represented 1% of total 2023 revenue

8

Core species supported by Zoetis: dogs, cats, horses, cattle (beef and dairy), swine, poultry, fish and sheep

7

Major product categories: parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical and animal health diagnostics

300

Approximate number of product lines

24

Manufacturing facilities around the world as of October 31, 2024

1,600

Approximate number of R&D colleagues as of December 31, 2023

4,100

Approximate field force members, as of December 31, 2023